Status:
UNKNOWN
Prediction of Outcomes After Surgery for Unruptured Intracranial Aneurysms
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
Macquarie University, Australia
University of Melbourne
Conditions:
Aneurysm, Brain
Eligibility:
All Genders
18+ years
Brief Summary
Accurate preoperative identification of patients at high risk for adverse outcomes would be clinically advantageous, as it would allow enhanced resource preparation, better surgical decision-making, e...
Detailed Description
Introduction Unruptured intracranial aneurysms (UIAs) are incidentally detected at an increasing rate, mostly owing to the rise in availability of non-invasive cranial imaging. Decision-making in UIAs...
Eligibility Criteria
Inclusion
- Adult patients (18 or older)
- Undergone microsurgical treatment for unruptured intracranial aneurysm
- Patients with prior SAH may only be included when surgical treatment occurred at least 4 weeks after ictus.
- Treated from January 1st 2010 onwards
Exclusion
- No specific exclusion criteria
Key Trial Info
Start Date :
May 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT04819074
Start Date
May 20 2021
End Date
October 1 2022
Last Update
December 21 2021
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
Barrow Neurological Institute
Phoenix, Arizona, United States, 85013
2
UCLA
Los Angeles, California, United States, 90095
3
UCSF
San Francisco, California, United States, 94143
4
Stanford University
Stanford, California, United States, 94305